Evidence map›Paper›PMID 36891541›Full record

ReviewAdvances in pharmacological and pharmaceutical sciences2023

Hepatoprotective Effect of Kaempferol: A Review of the Dietary Sources, Bioavailability, Mechanisms of Action, and Safety.

Maulana Yusuf Alkandahri, Barolym Tri Pamungkas, Zulpakor Oktoba, Mareetha Zahra Shafirany, Lela Sulastri, Maya Arfania, Ebta Narasukma Anggraeny, Ade Pratiwi, Fitri Dwi Astuti, Indriyani and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Advances in pharmacological and pharmaceutical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
13.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Total Flavonoids fromInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Kaempferol inhibits hepatitis B virus replicationFrontiers in cellular and infection microbiology · 2026
    Article
  8. Article
  9. Review
  10. Kaempferol-A Natural Drug for Rheumatoid Arthritis.Chinese journal of integrative medicine · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Hepatoprotective Effect of Kaempferol-A Review.Molecules (Basel, Switzerland) · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Maulana Yusuf AlkandahriFaculty of Pharmacy, Universitas Buana Perjuangan Karawang, Karawang, West Java, Indonesia.ORCID https://orcid.org/0000-0003-3402-4265
Barolym Tri PamungkasDepartment of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Mulawarman, Samarinda, East Kalimantan, Indonesia.
Zulpakor OktobaDepartment of Pharmacy, Faculty of Medicine, Universitas Lampung, Bandar Lampung, Indonesia.
Mareetha Zahra ShafiranyDepartment of Pharmaceutical Biology, Sekolah Tinggi Farmasi Muhammadiyah Cirebon, Cirebon, West Java, Indonesia.
Lela SulastriDepartment of Pharmaceutics and Pharmaceutical Technology, Sekolah Tinggi Farmasi Muhammadiyah Cirebon, Cirebon, West Java, Indonesia.
Maya ArfaniaFaculty of Pharmacy, Universitas Buana Perjuangan Karawang, Karawang, West Java, Indonesia.
Ebta Narasukma AnggraenyCollege of Pharmaceutical Sciences, Yayasan Pharmasi Semarang, Semarang, Central Java, Indonesia.
Ade PratiwiStudent of Pharmacy, Faculty of Pharmacy, Universitas Buana Perjuangan Karawang, Karawang, West Java, Indonesia.
Fitri Dwi AstutiStudent of Pharmacy, Faculty of Pharmacy, Universitas Buana Perjuangan Karawang, Karawang, West Java, Indonesia.
IndriyaniStudent of Pharmacy, Faculty of Pharmacy, Universitas Buana Perjuangan Karawang, Karawang, West Java, Indonesia.
Siti Yuliani DewiStudent of Pharmacy, Faculty of Pharmacy, Universitas Buana Perjuangan Karawang, Karawang, West Java, Indonesia.
Salsa Zulfa HamidahStudent of Pharmacy, Faculty of Pharmacy, Universitas Buana Perjuangan Karawang, Karawang, West Java, Indonesia.
Mercu Buana University · IDUniversitas Muhammadiyah Cirebon · IDLampung University · IDMulawarman University · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The liver is the body's most critical organ that performs vital functions. Hepatic disorders can affect the physiological and biochemical functions of the body. Hepatic disorder is a condition that describes the damage to cells, tissues, structures, and functions of the liver, which can cause fibrosis and ultimately result in cirrhosis. These diseases include hepatitis, ALD, NAFLD, liver fibrosis, liver cirrhosis, hepatic failure, and HCC. Hepatic diseases are caused by cell membrane rupture, immune response, altered drug metabolism, accumulation of reactive oxygen species, lipid peroxidation, and cell death. Despite the breakthrough in modern medicine, there is no drug that is effective in stimulating the liver function, offering complete protection, and aiding liver cell regeneration. Furthermore, some drugs can create adverse side effects, and natural medicines are carefully selected as new therapeutic strategies for managing liver disease. Kaempferol is a polyphenol contained in many vegetables, fruits, and herbal remedies. We use it to manage various diseases such as diabetes, cardiovascular disorders, and cancers. Kaempferol is a potent antioxidant and has anti-inflammatory effects, which therefore possesses hepatoprotective properties. The previous research has studied the hepatoprotective effect of kaempferol in various hepatotoxicity protocols, including acetaminophen (APAP)-induced hepatotoxicity, ALD, NAFLD, CCl

Identifiers

PMID36891541
PMCPMC9988374
OpenAlexW4322490114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.